Merz Pharmaceuticals and NascaCell Announce Collaboration Agreement to use Aptamers in the Validation of several Targets
31-Aug-2004 -
Frankfurt and Munich. Merz Pharmaceuticals and NascaCell announced that they have entered into a collaboration agreement. The focus is on the use of aptamers for the enhanced validation of different targets for products in research and development at Merz Pharmaceuticals.
"We are delighted to ...
aptamers
drug screening
oligonucleotides
+3